lithium carbonate has been researched along with Parkinson Disease in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (44.44) | 18.7374 |
| 1990's | 1 (11.11) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Nabekura, T; Uwai, Y | 1 |
| Guttuso, T | 1 |
| Coburn, KL; Doonan, SM; Lauterbach, EC; Mendez, MF; Shillcutt, SD; Victoroff, J | 1 |
| Andersen, PK; Brandt-Christensen, M; Kessing, LV; Kvist, K; Nilsson, FM | 1 |
| Coffey, CE; Ferren, EL; Olanow, CW; Ross, DR; Walker, JI | 1 |
| Coffey, CE; Ferren, EL; Olanow, CW; Ross, DR; Sullivan, JL | 1 |
| Glosser, DS; Hurtig, H; Kim, E; McAllister, TW; Stern, M; Zwil, AS | 1 |
| Marsden, CD; Quinn, N | 1 |
| Dilsaver, SC; Jaeckle, RS | 1 |
2 review(s) available for lithium carbonate and Parkinson Disease
| Article | Year |
|---|---|
High lithium levels in tobacco may account for reduced incidences of both Parkinson's disease and melanoma in smokers through enhanced β-catenin-mediated activity.
Topics: alpha-Synuclein; Alzheimer Disease; Autophagy; beta Catenin; beta-Glucosidase; Brain Chemistry; Drug Evaluation, Preclinical; Glycogen Synthase Kinase 3 beta; Humans; Incidence; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Lithium; Lithium Carbonate; Melanoma; Models, Biological; Mutation; Neuroprotective Agents; Nicotiana; Nuclear Receptor Subfamily 4, Group A, Member 2; Parkinson Disease; Parkinsonian Disorders; Smokers; Water; Wnt Signaling Pathway | 2019 |
Psychopharmacological neuroprotection in neurodegenerative disease: assessing the preclinical data.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Antipsychotic Agents; Benzodiazepines; Benzothiazoles; Brain; Clonazepam; Desipramine; Dibenzothiazepines; Dopamine Agonists; Humans; Lithium Carbonate; Maprotiline; Melatonin; Neurodegenerative Diseases; Neuroprotective Agents; Olanzapine; Parkinson Disease; Pramipexole; Quetiapine Fumarate; Selective Serotonin Reuptake Inhibitors; Valproic Acid | 2010 |
2 trial(s) available for lithium carbonate and Parkinson Disease
| Article | Year |
|---|---|
Treatment of the "on-off" phenomenon in Parkinsonism with lithium carbonate.
Topics: Adult; Aged; Female; Humans; Lithium; Lithium Carbonate; Male; Middle Aged; Parkinson Disease; Placebos; Time Factors | 1982 |
Lithium for painful dystonia in Parkinson's disease.
Topics: Adult; Clinical Trials as Topic; Delayed-Action Preparations; Double-Blind Method; Dystonia; Humans; Lithium; Lithium Carbonate; Middle Aged; Pain, Intractable; Parkinson Disease | 1986 |
5 other study(ies) available for lithium carbonate and Parkinson Disease
| Article | Year |
|---|---|
Relationship between lithium carbonate and the risk of Parkinson-like events in patients with bipolar disorders: A multivariate analysis using the Japanese adverse drug event report database.
Topics: Antimanic Agents; Bipolar Disorder; Drug-Related Side Effects and Adverse Reactions; Humans; Japan; Lithium; Lithium Carbonate; Middle Aged; Multivariate Analysis; Parkinson Disease; Valproic Acid | 2022 |
Treatment with antidepressants and lithium is associated with increased risk of treatment with antiparkinson drugs: a pharmacoepidemiological study.
Topics: Antidepressive Agents; Antimanic Agents; Antiparkinson Agents; Anxiety Disorders; Case-Control Studies; Denmark; Drug Prescriptions; Epidemiologic Studies; Female; Humans; Lithium Carbonate; Male; Mood Disorders; Parkinson Disease; Pharmacoepidemiology; Risk Factors | 2006 |
"On-off" syndrome treated with lithium carbonate: a case report.
Topics: Adult; Athetosis; Chorea; Humans; Levodopa; Lithium; Lithium Carbonate; Male; Parkinson Disease; Receptors, Dopamine | 1981 |
Treatment of organic bipolar mood disorders in Parkinson's disease.
Topics: Bipolar Disorder; Clozapine; Drug Therapy, Combination; Female; Humans; Levodopa; Lithium Carbonate; Male; Middle Aged; Parkinson Disease; Psychoses, Substance-Induced; Recurrence | 1994 |
Covariation of depressive symptoms, parkinsonism, and post-dexamethasone plasma cortisol levels in a bipolar patient: simultaneous response to ECT and lithium carbonate.
Topics: Bipolar Disorder; Brain; Dexamethasone; Electroconvulsive Therapy; Female; Humans; Hydrocortisone; Lithium; Lithium Carbonate; Middle Aged; Neurotransmitter Agents; Parkinson Disease | 1986 |